Improvement in hyperprolactinemia and reproductive comorbidities in patients with schizophrenia switched from conventional antipsychotics or risperidone to olanzapine
β Scribed by Bruce J. Kinon; Jonna Ahl; Hong Liu-Seifert; Gerald A. Maguire
- Book ID
- 113867100
- Publisher
- Elsevier Science
- Year
- 2006
- Tongue
- English
- Weight
- 227 KB
- Volume
- 31
- Category
- Article
- ISSN
- 0306-4530
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract A __post hoc__ analysis of the SPECTRUM trial was carried out to evaluate whether the improvements in efficacy and tolerability gained on switching to quetiapine occurred consistently for patients previously treated with either: haloperidol (__n__β=β43); olanzapine (__n__β=β66); or risp
## Abstract ## Background Atypical antipsychotics are commonly used in the management of schizophrenia in late life with evidence suggesting they induce lower rates of motor disturbance, but have similar efficacy to conventional antipsychotics. Trials in the elderly have been either retrospective,